Table 2 Retrospective cohort: second-line chemotherapy used
Chemotherapy regimen | n. (%) |
|---|---|
Monotherapy with 5-fluorouracil or capecitabine | 49 (28) |
Gemcitabine plus 5-fluorouracil or capecitabine | 38 (22) |
Capecitabine plus mytomicin-C | 21 (12) |
FOLFIRI or XELIRI | 17 (10) |
Retreatment with gemcitabine plus cisplatin or oxaliplatin | 13 (7) |
FOLFOX or XELOX | 10 (6) |
Epirubicin plus cisplatin plus 5-fluorouracil | 9 (5) |
Gemcitabine plus irinotecan | 6 (3) |
Monotherapy with gemcitabine | 4 (2) |
Other regimens | 7 (4) |